Posted by Michael Wonder on 21 Mar 2024
FDA approves non-steroidal treatment for Duchenne muscular dystrophy
21 March 2024 - Today, the US FDA approved Duvyzat (givinostat) oral medication for the treatment of Duchenne muscular dystrophy in patients six years of age and older.
Duvyzat is the first non-steroidal drug approved to treat patients with all genetic variants of Duchenne muscular dystrophy.
